PATENT CLAIM ANALYSIS

Application Number: 16300651
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "222200"]

Abstract:
There is provided for novel therapy of sleep apnea that involves administering the drug sultiame to the patient.

Claim (Index 3):
Sultiame for use according to  claim 1  where the patient has an Apnea Hypopnea Index of 15 n/h or more.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10598114', '14269326', '13359692', '13143152', '13640711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7618460079483004
- 35 USC 102 Novelty (BERT): 0.5103351917027842
- Combined Prediction Score: 0.7366949263237488
- Mean Citation Score: 212.574834
- Max Citation Score: 238.74628
- Similarity Product: 147.74343761980538

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test